UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy

BMC infectious diseases, 2018-05, Vol.18 (1), p.212-212, Article 212

2018

Volltextzugriff (PDF)

Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

Malaria journal, 2012-03, Vol.11 (1), p.91-91, Article 91

2012

Volltextzugriff (PDF)

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

BMC infectious diseases, 2012-02, Vol.12 (1), p.38-38, Article 38

2012

Volltextzugriff (PDF)

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy : prevalence, risk factors and virological outcome

Antiviral therapy, 2006-01, Vol.11 (5), p.553-560

2006

Volltextzugriff (PDF)

Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period

Current HIV research, 2012-10, Vol.10 (7), p.606

2012

Volltextzugriff (PDF)

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

Clinical infectious diseases, 2004-02, Vol.38 (3), p.433-437

2004

Volltextzugriff (PDF)

Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons

European journal of drug metabolism and pharmacokinetics, 2022, Vol.47 (1), p.135-142

2022

Volltextzugriff (PDF)

Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world

Journal of antimicrobial chemotherapy, 2018-01, Vol.73 (1), p.160-164

2018

Volltextzugriff (PDF)

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

AIDS (London), 2019-03, Vol.33 (3), p.493-502

2019

Volltextzugriff (PDF)

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

International journal of infectious diseases, 2021-04, Vol.105, p.532-539

2021

Volltextzugriff (PDF)

Radiation therapy in the treatment of HIV-related Kaposi's sarcoma

Anticancer research, 2013-05, Vol.33 (5), p.2153-2157

2013

Volltextzugriff (PDF)

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA

Journal of clinical virology, 2016-09, Vol.82, p.94-100

2016

Volltextzugriff (PDF)

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients

Current HIV research, 2009-07, Vol.7 (4), p.425

2009

Volltextzugriff (PDF)

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for Latent Mycobacterium tuberculosis Infection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence

The Journal of infectious diseases, 2015-06, Vol.211 (11), p.1852-1853

2015

Volltextzugriff (PDF)

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

Journal of acquired immune deficiency syndromes (1999), 2015-12, Vol.70 (4), p.e147

2015

Volltextzugriff (PDF)

A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz

Journal of acquired immune deficiency syndromes (1999), 2012-01, Vol.59 (1), p.18

2012

Volltextzugriff (PDF)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

BMC infectious diseases, 2016-08, Vol.16 (1), p.401-401, Article 401

2016

Volltextzugriff (PDF)

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians

BMC infectious diseases, 2017-11, Vol.17 (1), p.734-734, Article 734

2017

Volltextzugriff (PDF)

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

Journal of neurovirology, 2005-07, Vol.11 (3), p.265-273

2005

Volltextzugriff (PDF)

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

Journal of antimicrobial chemotherapy, 2013-01, Vol.68 (1), p.193-199

2013

Volltextzugriff (PDF)

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Journal of antimicrobial chemotherapy, 2006-10, Vol.58 (4), p.714-722

2006

Volltextzugriff (PDF)

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART

AIDS research and human retroviruses, 2005-08, Vol.21 (8), p.706-713

2005

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study

Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy : prevalence, risk factors and virological outcome

Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons

Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

Radiation therapy in the treatment of HIV-related Kaposi's sarcoma

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for Latent Mycobacterium tuberculosis Infection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians

Impact of pre-therapy viral load on virological response to modern first-line HAART

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART

Aktive Filter

Suchergebnisse filtern